201 related articles for article (PubMed ID: 37257708)
41. [Mechanism of Xuebijing Injection in treatment of sepsis-associated ARDS based on network pharmacology and in vitro experiment].
Ding WC; Chen J; Liao HY; Feng J; Wang J; Zhang YH; Ji XH; Chen Q; Wu XY; Sun ZR; Nie SN
Zhongguo Zhong Yao Za Zhi; 2023 Jun; 48(12):3345-3359. PubMed ID: 37382018
[TBL] [Abstract][Full Text] [Related]
42. Tanshinone IIA inhibits the adipogenesis and inflammatory response in ox-LDL-challenged human monocyte-derived macrophages via regulating miR-130b/WNT5A.
Yuan L; Li Q; Zhang Z; Liu Q; Wang X; Fan L
J Cell Biochem; 2020 Feb; 121(2):1400-1408. PubMed ID: 31512787
[TBL] [Abstract][Full Text] [Related]
43. PM
Liang S; Sun Q; Du Z; Ren X; Xu Q; Sun Z; Duan J
Nanotoxicology; 2022 Apr; 16(3):290-309. PubMed ID: 35653618
[TBL] [Abstract][Full Text] [Related]
44. Puerarin inhibits Mycoplasma gallisepticum (MG-HS)-induced inflammation and apoptosis via suppressing the TLR6/MyD88/NF-κB signal pathway in chicken.
Niu L; Luo R; Zou M; Sun Y; Fu Y; Wang Y; Peng X
Int Immunopharmacol; 2020 Nov; 88():106993. PubMed ID: 33182066
[TBL] [Abstract][Full Text] [Related]
45. Tacrolimus reduces atherosclerotic plaque formation in ApoE
Li X; Shang X; Sun L
Exp Ther Med; 2020 Feb; 19(2):1393-1399. PubMed ID: 32010314
[TBL] [Abstract][Full Text] [Related]
46. Therapy for myocardial infarction: In vitro and in vivo evaluation of puerarin-prodrug and tanshinone co-loaded lipid nanoparticulate system.
Guo J; Xing X; Lv N; Zhao J; Liu Y; Gong H; Du Y; Lu Q; Dong Z
Biomed Pharmacother; 2019 Dec; 120():109480. PubMed ID: 31562980
[TBL] [Abstract][Full Text] [Related]
47. Hypoxia induces netrin-1 and Unc5b in atherosclerotic plaques: mechanism for macrophage retention and survival.
Ramkhelawon B; Yang Y; van Gils JM; Hewing B; Rayner KJ; Parathath S; Guo L; Oldebeken S; Feig JL; Fisher EA; Moore KJ
Arterioscler Thromb Vasc Biol; 2013 Jun; 33(6):1180-8. PubMed ID: 23599441
[TBL] [Abstract][Full Text] [Related]
48. Cholesterol and HIF-1α: Dangerous Liaisons in Atherosclerosis.
Thomas C; Leleu D; Masson D
Front Immunol; 2022; 13():868958. PubMed ID: 35386720
[TBL] [Abstract][Full Text] [Related]
49. Identification of bioactive compounds and potential mechanisms of scutellariae radix-coptidis rhizoma in the treatment of atherosclerosis by integrating network pharmacology and experimental validation.
Ji L; Song T; Ge C; Wu Q; Ma L; Chen X; Chen T; Chen Q; Chen Z; Chen W
Biomed Pharmacother; 2023 Sep; 165():115210. PubMed ID: 37499457
[TBL] [Abstract][Full Text] [Related]
50. Sonodynamic therapy suppresses matrix collagen degradation in vulnerable atherosclerotic plaque by modulating caspase 3 - PEDF/HIF-1α - MMP-2/MMP-9 signaling in macrophages.
Tian Y; Sheng S; Gao W; Yao J; Tian Y
PLoS One; 2022; 17(12):e0279191. PubMed ID: 36574366
[TBL] [Abstract][Full Text] [Related]
51. The regulated profile of noncoding RNAs associated with inflammation by tanshinone IIA on atherosclerosis.
Chen W; Guo S; Li X; Song N; Wang D; Yu R
J Leukoc Biol; 2020 Jul; 108(1):243-252. PubMed ID: 32337768
[TBL] [Abstract][Full Text] [Related]
52. Mechanism of Tao Hong Decoction in the treatment of atherosclerosis based on network pharmacology and experimental validation.
Li S; Liu P; Feng X; Du M; Zhang Y; Wang Y; Wang J
Front Cardiovasc Med; 2023; 10():1111475. PubMed ID: 36776258
[TBL] [Abstract][Full Text] [Related]
53. Stage-dependent differential effects of interleukin-1 isoforms on experimental atherosclerosis.
Vromman A; Ruvkun V; Shvartz E; Wojtkiewicz G; Santos Masson G; Tesmenitsky Y; Folco E; Gram H; Nahrendorf M; Swirski FK; Sukhova GK; Libby P
Eur Heart J; 2019 Aug; 40(30):2482-2491. PubMed ID: 30698710
[TBL] [Abstract][Full Text] [Related]
54. Succinate induces synovial angiogenesis in rheumatoid arthritis through metabolic remodeling and HIF-1α/VEGF axis.
Li Y; Liu Y; Wang C; Xia WR; Zheng JY; Yang J; Liu B; Liu JQ; Liu LF
Free Radic Biol Med; 2018 Oct; 126():1-14. PubMed ID: 30030103
[TBL] [Abstract][Full Text] [Related]
55. Hydroxysafflor yellow A regulates lymphangiogenesis and inflammation via the inhibition of PI3K on regulating AKT/mTOR and NF-κB pathway in macrophages to reduce atherosclerosis in ApoE-/- mice.
Feng X; Du M; Li S; Zhang Y; Ding J; Wang J; Wang Y; Liu P
Phytomedicine; 2023 Apr; 112():154684. PubMed ID: 36738477
[TBL] [Abstract][Full Text] [Related]
56. Hypoxia-inducible factor-1α/interleukin-1β signaling enhances hepatoma epithelial-mesenchymal transition through macrophages in a hypoxic-inflammatory microenvironment.
Zhang J; Zhang Q; Lou Y; Fu Q; Chen Q; Wei T; Yang J; Tang J; Wang J; Chen Y; Zhang X; Zhang J; Bai X; Liang T
Hepatology; 2018 May; 67(5):1872-1889. PubMed ID: 29171040
[TBL] [Abstract][Full Text] [Related]
57. Soluble Uric Acid Promotes Atherosclerosis via AMPK (AMP-Activated Protein Kinase)-Mediated Inflammation.
Kimura Y; Yanagida T; Onda A; Tsukui D; Hosoyamada M; Kono H
Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):570-582. PubMed ID: 31996020
[TBL] [Abstract][Full Text] [Related]
58. Tanshinone IIA Suppresses Proliferation and Inflammatory Cytokine Production of Synovial Fibroblasts from Rheumatoid Arthritis Patients Induced by TNF-α and Attenuates the Inflammatory Response in AIA Mice.
Du H; Wang Y; Zeng Y; Huang X; Liu D; Ye L; Li Y; Chen X; Liu T; Li H; Wu J; Yu Q; Wu Y; Jie L
Front Pharmacol; 2020; 11():568. PubMed ID: 32499694
[TBL] [Abstract][Full Text] [Related]
59. Tanshinone IIA mediates protection from diabetes kidney disease by inhibiting oxidative stress induced pyroptosis.
Wu Q; Guan YB; Zhang KJ; Li L; Zhou Y
J Ethnopharmacol; 2023 Nov; 316():116667. PubMed ID: 37257702
[TBL] [Abstract][Full Text] [Related]
60. Tanshinone IIA promotes apoptosis by downregulating BCL2 and upregulating TP53 in triple-negative breast cancer.
Liu J; Zhang C; Liu S; Wang X; Wu X; Hao J
Naunyn Schmiedebergs Arch Pharmacol; 2023 Feb; 396(2):365-374. PubMed ID: 36374307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
